NASDAQ : IBRX
ImmunityBio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 8.27 USD (Oct 30, 2026, 12:41 PM EDT) · Market cap 8.76B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
ImmunityBio, Inc. (IBRX) reported revenue of 165.79M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 164.89M | 112.98M | 14.15M | 934.00K | ||
| Other Revenue | 901.00K | 306.00K | 595.00K | 622.00K | 240.00K | |
| Revenue | 165.79M | 113.29M | 14.74M | 622.00K | 240.00K | 934.00K |
| Cost of Revenue | 1.09M | 753.00K | ||||
| Gross Profit | 164.70M | 112.53M | 14.74M | 622.00K | 240.00K | 934.00K |
| Selling, General & Admin | 172.60M | 150.00M | 168.78M | 129.62M | 108.71M | 126.76M |
| Research & Development | 243.89M | 218.56M | 190.14M | 232.37M | 242.20M | 191.60M |
| Operating Expenses | 416.50M | 368.56M | 358.93M | 361.99M | 350.91M | 318.36M |
| Operating Income | -251.80M | -256.03M | -344.18M | -361.36M | -350.67M | -317.42M |
| Interest Expense | -114.48M | -112.53M | -154.33M | -129.20M | -63.52M | -14.85M |
| Interest & Investment Income | 9.83M | 6.41M | 7.97M | 1.13M | ||
| Earnings From Equity Investments | -7.55M | -12.11M | -803.00K | |||
| Other Non Operating Income (Expenses) | -628.73M | 10.54M | 77.52M | -84.44M | 16.91M | 4.81M |
| EBT Excluding Unusual Items | -985.18M | -351.61M | -413.01M | -581.41M | -409.38M | -328.27M |
| Merger & Restructuring Charges | -13.00M | |||||
| Gain (Loss) on Sale of Investments | -632.00K | -1.59M | -7.28M | -8.71M | ||
| Asset Writedown | -886.00K | -681.00K | ||||
| Other Unusual Items | -7.40M | 51.00K | 144.00K | |||
| Pretax Income | -992.58M | -351.61M | -413.64M | -583.89M | -417.29M | -349.84M |
| Income Tax Expense | -161.00K | -135.00K | -40.00K | 34.00K | 9.00K | |
| Earnings From Continuing Operations | -992.42M | -351.47M | -413.64M | -583.85M | -417.32M | -349.85M |
| Minority Interest in Earnings | 62.00K | 74.00K | 81.00K | 656.00K | 753.00K | 3.06M |
| Net Income | -992.36M | -351.40M | -413.56M | -583.20M | -416.57M | -346.79M |
| Net Income to Common | -992.36M | -351.40M | -413.56M | -583.20M | -416.57M | -346.79M |
| Shares Outstanding (Basic) | 1.00B | 919.86M | 697.31M | 508.64M | 399.90M | 389.23M |
| Shares Outstanding (Diluted) | 1.00B | 919.86M | 700.44M | 508.64M | 399.90M | 389.23M |
| EPS (Basic) | -0.99 | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 |
| EPS (Diluted) | -0.99 | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 |
| Free Cash Flow | -288.07M | -308.78M | -398.12M | -397.34M | -415.67M | -307.98M |
| Free Cash Flow Per Share | -0.29 | -0.34 | -0.57 | -0.78 | -1.04 | -0.79 |
| Gross Margin | 99.34% | 99.33% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -151.88% | -226.00% | -2,334.23% | -58,097.11% | -146,111.67% | -33,985.44% |
| Profit Margin | -598.55% | -310.18% | -2,804.77% | -93,761.41% | -173,569.58% | -37,129.55% |
| Free Cash Flow Margin | -173.76% | -272.56% | -2,700.06% | -63,881.19% | -173,196.25% | -32,974.52% |
| EBITDA | -235.30M | -240.60M | -326.63M | -342.85M | -332.41M | -303.19M |
| EBITDA Margin | -141.92% | -212.38% | ||||
| D&A For EBITDA | 16.50M | 15.43M | 17.55M | 18.51M | 18.26M | 14.24M |
| EBIT | -251.80M | -256.03M | -344.18M | -361.36M | -350.67M | -317.42M |
| EBIT Margin | -151.88% | -226.00% | ||||
| Revenue as Reported | 165.79M | 113.29M | 14.74M | 622.00K | 240.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 75.67M | 88.33M | 143.43M | 265.45M | 104.64M | 181.10M |
| Short-Term Investments | 281.70M | 154.48M | 6.38M | 1.01M | 2.54M | 136.01M |
| Cash & Short-Term Investments | 357.37M | 242.82M | 149.81M | 266.46M | 107.18M | 317.12M |
| Accounts Receivable | 53.47M | 42.57M | 2.36M | |||
| Other Receivables | 27.00K | 46.00K | 293.00K | 3.17M | 1.89M | 1.33M |
| Receivables | 53.50M | 42.62M | 2.65M | 3.17M | 1.89M | 1.33M |
| Inventory | 1.94M | 910.00K | 8.27M | 2.16M | ||
| Prepaid Expenses | 26.17M | 16.85M | 16.73M | 13.98M | 14.74M | 12.25M |
| Other Current Assets | 11.68M | 7.12M | 10.47M | 14.60M | 3.65M | |
| Total Current Assets | 438.98M | 314.88M | 184.59M | 294.08M | 140.58M | 334.35M |
| Property, Plant & Equipment | 145.69M | 147.54M | 170.46M | 182.68M | 189.58M | 119.17M |
| Long-Term Investments | 14.21M | 700.00K | 891.00K | 840.00K | 7.60M | |
| Goodwill | 910.00K | 910.00K | ||||
| Other Intangible Assets | 11.84M | 13.04M | 15.02M | 17.09M | 20.00M | 1.42M |
| Other Long-Term Assets | 32.00M | 3.94M | 4.13M | 2.82M | 4.72M | |
| Total Assets | 628.50M | 501.90M | 382.93M | 504.45M | 362.36M | 468.91M |
| Accounts Payable | 12.00M | 6.98M | 6.72M | 9.20M | 21.02M | 11.42M |
| Accrued Expenses | 56.02M | 42.01M | 38.28M | 39.53M | 34.23M | 33.94M |
| Short-Term Debt | 1.75M | 1.25M | 1.48M | 433.32M | 301.83M | |
| Current Portion of Leases | 7.56M | 7.59M | 7.47M | 5.31M | 2.73M | 3.01M |
| Other Current Liabilities | 1.15M | 3.42M | 1.22M | 2.77M | 9.57M | 18.80M |
| Total Current Liabilities | 76.73M | 61.75M | 54.94M | 58.28M | 500.86M | 369.00M |
| Long-Term Debt | 1.19B | 801.71M | 746.28M | 836.95M | 241.27M | 306.35M |
| Long-Term Leases | 31.40M | 33.67M | 34.82M | 39.94M | 48.02M | 37.07M |
| Other Long-Term Liabilities | 376.70M | 104.34M | 35.01M | 155.21M | 22.03M | 411.00K |
| Total Liabilities | 1.67B | 1.00B | 871.06M | 1.09B | 812.18M | 712.82M |
| Common Stock | 105.00K | 101.00K | 85.00K | 67.00K | 42.00K | 40.00K |
| Additional Paid-In Capital | 3.52B | 3.20B | 2.88B | 2.37B | 1.93B | 1.72B |
| Retained Earnings | -4.59B | -3.73B | -3.38B | -2.96B | -2.38B | -1.96B |
| Comprehensive Income & Other | 27.28M | 28.96M | 1.20M | 10.00K | 183.00K | 4.00K |
| Total Common Equity | -1.05B | -500.47M | -489.10M | -586.99M | -447.33M | -242.17M |
| Minority Interest | 868.00K | 895.00K | 969.00K | 1.05M | -2.49M | -1.74M |
| Shareholders' Equity | -1.05B | -499.57M | -488.13M | -585.94M | -449.82M | -243.91M |
| Total Liabilities & Equity | 628.50M | 501.90M | 382.93M | 504.45M | 362.36M | 468.91M |
| Total Debt | 1.23B | 844.72M | 789.82M | 883.68M | 725.33M | 648.26M |
| Net Cash (Debt) | -871.03M | -601.90M | -640.01M | -616.32M | -617.31M | -330.32M |
| Net Cash Per Share | -0.87 | -0.65 | -0.91 | -1.21 | -1.54 | -0.85 |
| Filing Date Shares Outstanding | 1.06B | 1.03B | 853.44M | 673.95M | 435.84M | 397.91M |
| Total Common Shares Outstanding | 1.05B | 1.01B | 852.90M | 670.87M | 421.57M | 397.83M |
| Working Capital | 362.25M | 253.12M | 129.64M | 235.80M | -360.28M | -34.65M |
| Book Value Per Share | -0.99 | -0.49 | -0.57 | -0.87 | -1.06 | -0.61 |
| Tangible Book Value | -1.06B | -514.42M | -505.03M | -604.08M | -467.33M | -243.59M |
| Tangible Book Value Per Share | -1.00 | -0.51 | -0.59 | -0.90 | -1.11 | -0.61 |
| Machinery | 65.13M | 75.44M | 71.80M | 69.85M | 55.34M | |
| Construction In Progress | 86.43M | 86.42M | 84.44M | 72.69M | 16.57M | |
| Leasehold Improvements | 73.14M | 73.13M | 72.55M | 68.71M | 62.48M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -992.36M | -351.40M | -413.56M | -583.20M | -416.57M | -346.79M |
| Depreciation & Amortization | 16.50M | 15.43M | 17.55M | 18.51M | 18.26M | 14.24M |
| Other Amortization | 100.00K | 100.00K | 22.59M | 42.40M | 16.28M | 62.00K |
| Asset Writedown & Restructuring Costs | 14.02M | 14.02M | 886.00K | 2.01M | ||
| Loss (Gain) From Sale of Investments | -6.48M | -2.75M | -857.00K | 1.45M | 5.51M | 5.02M |
| Stock-Based Compensation | 34.31M | 36.81M | 34.43M | 49.16M | 40.18M | 57.18M |
| Other Operating Activities | 680.42M | 37.18M | -31.97M | 100.20M | 4.82M | 14.98M |
| Change in Accounts Receivable | -31.35M | -40.21M | -2.36M | |||
| Change in Inventory | -11.93M | -6.33M | -8.27M | |||
| Change in Accounts Payable | 3.24M | -190.00K | -3.17M | -6.48M | 8.00M | -3.72M |
| Change in Other Net Operating Assets | 12.38M | -7.60M | -5.62M | 10.30M | -16.00M | -15.39M |
| Operating Cash Flow | -281.14M | -304.94M | -391.24M | -366.76M | -337.51M | -274.42M |
| Capital Expenditures | -6.94M | -3.85M | -6.89M | -30.58M | -78.16M | -33.56M |
| Sale of Property, Plant & Equipment | 20.50M | |||||
| Sale (Purchase) of Intangibles | -440.00K | -406.00K | -21.23M | |||
| Investment in Securities | -269.53M | -145.55M | -5.36M | 114.00K | 126.69M | -71.82M |
| Investing Cash Flow | -276.91M | -149.80M | -12.25M | -30.47M | 27.30M | -84.89M |
| Short-Term Debt Issued | 2.88M | |||||
| Long-Term Debt Issued | 96.96M | 451.46M | 174.12M | 338.50M | ||
| Total Debt Issued | 77.89M | 2.88M | 96.96M | 451.46M | 174.12M | 338.50M |
| Long-Term Debt Repaid | -1.16M | -64.00K | -77.00K | -58.00K | ||
| Net Debt Issued (Repaid) | 74.96M | 1.72M | 96.89M | 451.39M | 174.07M | 338.50M |
| Issuance of Common Stock | 429.88M | 400.78M | 190.20M | 100.86M | 60.50M | 169.99M |
| Repurchase of Common Stock | -8.05M | -2.27M | -5.46M | -3.44M | -616.00K | -4.06M |
| Other Financing Activities | 9.54M | -339.00K | 1.02M | |||
| Financing Cash Flow | 496.78M | 400.24M | 281.63M | 558.34M | 233.61M | 505.44M |
| Foreign Exchange Rate Adjustments | 68.00K | 15.00K | -23.00K | -292.00K | 284.00K | 48.00K |
| Net Cash Flow | -61.20M | -54.48M | -121.88M | 160.82M | -76.31M | 146.19M |
| Free Cash Flow | -288.07M | -308.78M | -398.12M | -397.34M | -415.67M | -307.98M |
| Free Cash Flow Margin | -173.76% | -272.56% | -2,700.06% | -63,881.19% | -173,196.25% | -32,974.52% |
| Free Cash Flow Per Share | -0.29 | -0.34 | -0.57 | -0.78 | -1.04 | -0.79 |
| Levered Free Cash Flow | -186.56M | -213.36M | -256.31M | -234.66M | -299.03M | -170.30M |
| Unlevered Free Cash Flow | -115.01M | -143.03M | -182.44M | -196.31M | -275.62M | -161.08M |
| Cash Interest Paid | 76.94M | 71.32M | 92.32M | 77.19M | 35.44M | 2.11M |
| Cash Income Tax Paid | 5.00K | 15.00K | 8.00K | 2.00K | 9.00K | |
| Change in Working Capital | -27.65M | -54.33M | -19.42M | 3.83M | -8.00M | -19.11M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.79B | 1.95B | 1.87B | 3.35B | 2.08B | 2.42B |
| Enterprise Value | 9.66B | 2.55B | 2.76B | 3.88B | 2.68B | 2.68B |
| Last Close Price | 8.29 | 1.98 | 2.56 | 5.02 | 5.07 | 6.08 |
| PS Ratio | 52.99 | 17.21 | 126.77 | 5,388.88 | 8,648.47 | 2,589.53 |
| PB Ratio | -3.90 | -3.83 | -5.72 | -4.61 | -9.92 | |
| EV/Sales Ratio | 58.25 | 22.53 | 187.09 | 6,241.20 | 11,149.27 | 2,870.55 |
| Debt / Equity Ratio | -1.18 | -1.69 | -1.62 | -1.51 | -1.61 | -2.66 |
| Net Debt / Equity Ratio | -0.83 | -1.21 | -1.31 | -1.05 | -1.37 | -1.35 |
| Net Debt / EBITDA Ratio | -3.70 | -2.50 | -1.96 | -1.80 | -1.86 | -1.09 |
| Net Debt / FCF Ratio | -3.02 | -1.95 | -1.61 | -1.55 | -1.49 | -1.07 |
| Asset Turnover | 0.32 | 0.26 | 0.03 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.26 | 0.16 | ||||
| Quick Ratio | 5.36 | 4.62 | 2.77 | 4.63 | 0.22 | 0.86 |
| Current Ratio | 5.72 | 5.10 | 3.36 | 5.05 | 0.28 | 0.91 |
| Return on Assets (ROA) | -30.54% | -36.17% | -48.48% | -52.11% | -52.73% | -57.48% |
| Return on Capital Employed (ROCE) | -45.60% | -58.20% | -104.90% | -81.00% | 253.20% | -317.70% |
| Earnings Yield | -11.93% | -18.02% | -22.12% | -17.40% | -20.07% | -14.34% |
| FCF Yield | -3.28% | -15.83% | -21.30% | -11.85% | -20.03% | -12.73% |
| Buyback Yield / Dilution | -26.61% | -31.33% | -37.71% | -27.19% | -2.74% | -3.23% |